[1] STERNER R M, STERNER R C, BRENES-SALAZAR J A, et al. Cellular therapies for chronic ischemic heart failure[J].Hellenic J Cardiol,2018,59(2):78-90. [2] YIN Z Q, XING W H. Progress in gene therapy for chronic heart failure[J].Heart Surg Forum,2018,21(2):75-83. [3] WANG Y, WANG Q, LI C, et al. A review of chinese herbal medicine for the treatment of chronic heart failure[J].Curr Pharm Des,2017,23(34):5115-5124. [4] 周云洁,高原,宋歌. 桂枝甘草汤联合曲美他嗪对慢性心力衰竭患者的临床疗效[J].中成药,2020,42(5):1187-1191. [5] 胡志明,欧阳家和,李延菁,等. 卡格列净对心力衰竭的影响[J].重庆医科大学学报,2021,46(2):142-145. [6] 杨杰孚,王华,柴坷. 2018中国心力衰竭诊断和治疗指南亮点[J].中国心血管病研究,2018,16(12):1057-1060. [7] 周仲瑛.中医内科学[M].北京:中国中医药出版社,2017:10. [8] 张小红,吴跃明,刘宏. 丹参酮ⅡA联合重组人脑钠肽治疗充血性心力衰竭的临床疗效及安全性评价[J].中国临床药理学杂志,2015,31(18):1815-1817. [9] BRENNAN E J. Chronic heart failure nursing: integrated multidisciplinary care[J].Br J Nurs,2018,27(12):681-688. [10] CAPRIOTTI T, MICARI M. Chronic heart failure treatment with the left ventricular assist device[J].Home Healthc Now,2019,37(4):190-197. [11] GOLDSTEIN D, FRISHMAN W H. Diastolic heart failure: A review of current and future treatment options[J].Cardiol Rev,2021,29(2):82-88. [12] HAO P, JIANG F, CHENG J, et al. Traditional chinese medicine for cardiovascular disease: Evidence and potential mechanisms[J].J Am Coll Cardiol,2017,69(24):2952-2966. [13] 桑岚. 桂枝甘草龙骨牡蛎加味汤治疗冠状动脉粥样硬化性心脏病室性早搏40例临床评价[J].中国药业,2017,26(18):40-42. [14] 翟鑫,罗德钦,管频,等. 卡格列净治疗2型糖尿病合并心血管高风险患者的安全性及其对相关指标的影响[J].中国药房,2020,31(16):2005-2009. [15] 何玲鸽.D-二聚体联合NT-proBNP预测急性心力衰竭患者近期死亡风险的临床价值[J].医学临床研究,2022,39(6):869. [16] 傅梦薇,韩宜臻,彭煜,等. 桂枝甘草汤对运动性贫血大鼠血浆总超氧化物歧化酶和血清铁的影响[J].长春中医药大学学报,2018,34(3):412-415.
2024, Vol. 41 
